Drug-induced eosinophilia

Allergy Asthma Proc. 2018 May 1;39(3):252-256. doi: 10.2500/aap.2018.39.4120.

Abstract

Background: Drug reactions have been associated with increased blood eosinophil levels.

Objective: To review clinical characteristics, the diagnosis, and the management of drug-induced eosinophilia.

Methods: Pertinent articles were selected and reviewed in relation to a case presentation of drug-induced eosinophilia.

Results: A case of asymptomatic eosinophilia in the setting of acetylsalicylic acid (aspirin) use was presented, followed by discussion of the clinical characteristics, diagnosis, and management of drug-induced eosinophilia. Clinical pearls and pitfalls were reviewed for the practicing allergist, clinical immunologist, and fellow-in-training.

Conclusion: Drug-induced eosinophilia is a diagnosis of exclusion. Although most cases of drug-induced eosinophilia are asymptomatic, one study showed an increased rate of hypersensitivity reactions in patients with higher eosinophil counts and earlier onset of eosinophilia.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Allergens / immunology
  • Aspirin / immunology
  • Asymptomatic Diseases
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / drug therapy
  • Cardiomyopathies / immunology*
  • Drug Hypersensitivity / diagnosis
  • Drug Hypersensitivity / drug therapy
  • Drug Hypersensitivity / immunology*
  • Eosinophilia / diagnosis
  • Eosinophilia / drug therapy
  • Eosinophilia / immunology*
  • Eosinophils / immunology*
  • Humans
  • Leukocyte Count
  • Male
  • Prednisone / therapeutic use*

Substances

  • Allergens
  • Aspirin
  • Prednisone